When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APLS - Apellis Pharma's APL-2 successful in PNH study; shares up 49% premarket
Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals (NASDAQ:APLS) jumps 49% premarket on robust volume in reaction to positive results from a Phase 3 clinical trial, PEGASUS, evaluating pegcetacoplan (APL-2) in adults with paroxysmal nocturnal hemoglobinuria (PNH).
More news on: Apellis Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,